Visikol Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A

Visikol General Information

Description

Developer of tissue clearing and 3D imaging technology catering to researchers, developers and pathologists in the drug discovery sector. The company offers technology based on vitro cell culture that leverages the company technology combined with confocal imaging and quantitative histology to provide 3D in vitro assays that extract all the data from advanced models, thereby enabling clients to capture high-resolution images in 3D from biological tissues.

Contact Information

Website
www.visikol.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 53 Frontage Road
  • Suite 120, Shelbourne Building
  • Hampton, NJ 08827
  • United States
+1 (800)
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Sartorius
Vertical(s)
Life Sciences
Corporate Office
  • 53 Frontage Road
  • Suite 120, Shelbourne Building
  • Hampton, NJ 08827
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Visikol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 04-Apr-2025 Completed Generating Revenue
7. Merger/Acquisition 20-May-2021 Completed Generating Revenue
6. Grant 01-May-2021 Completed Generating Revenue
5. Grant 17-Apr-2019 Completed Generating Revenue
4. Early Stage VC 30-Dec-2017 Completed Generating Revenue
3. Grant 31-Dec-2016 Completed Generating Revenue
2. Grant 20-Jun-2016 $225K $500K Completed Generating Revenue
1. Seed Round 23-Feb-2016 $500K $500K Completed Generating Revenue
To view Visikol’s complete valuation and funding history, request access »

Visikol Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tissue clearing and 3D imaging technology catering to researchers, developers and pathologists in the drug
Other Pharmaceuticals and Biotechnology
Hampton, NJ
12 As of 2021

Saint-Sulpice, Switzerland
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Visikol Competitors (13)

One of Visikol’s 13 competitors is Nagi Bioscience, a Venture Capital-Backed company based in Saint-Sulpice, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nagi Bioscience Venture Capital-Backed Saint-Sulpice, Switzerland
VivoSim Labs Formerly VC-backed San Diego, CA
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
Hesperos Venture Capital-Backed Orlando, FL
AMS Biotechnology (Europe) Private Equity-Backed Abingdon, United Kingdom
You’re viewing 5 of 13 competitors. Get the full list »

Visikol Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Visikol Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3857200-A1 Detection of biologicals penetration into tissue surrogates Inactive 26-Sep-2018
EP-3857200-A4 Detection of biologicals penetration into tissue surrogates Inactive 26-Sep-2018
US-20210382040-A1 Detection of biologicals penetration into tissue surrogates Inactive 26-Sep-2018
WO-2020068060-A1 Detection of biologicals penetration into tissue surrogates Inactive 26-Sep-2018
WO-2019164473-A1 Method for visualization of 3-d tissue cultures Inactive 20-Feb-2018 G01N1/30
To view Visikol’s complete patent history, request access »

Visikol Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Visikol Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
BICO Group Corporation Majority
Angel (individual) Minority
Foundation Venture Capital Group Venture Capital Minority
National Institutes of Health Government Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Visikol FAQs

  • When was Visikol founded?

    Visikol was founded in 2012.

  • Where is Visikol headquartered?

    Visikol is headquartered in Hampton, NJ.

  • What is the size of Visikol?

    Visikol has 12 total employees.

  • What industry is Visikol in?

    Visikol’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Visikol a private or public company?

    Visikol is a Private company.

  • What is Visikol’s current revenue?

    The current revenue for Visikol is .

  • How much funding has Visikol raised over time?

    Visikol has raised $500K.

  • Who are Visikol’s investors?

    , BICO Group, , Foundation Venture Capital Group, and National Institutes of Health are 5 of 6 investors who have invested in Visikol.

  • Who are Visikol’s competitors?

    Nagi Bioscience, VivoSim Labs, Aspect Biosystems, Hesperos, and AMS Biotechnology (Europe) are some of the 13 competitors of Visikol.

  • When was Visikol acquired?

    Visikol was acquired on 04-Apr-2025.

  • Who acquired Visikol?

    Visikol was acquired by Sartorius.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process